0001209191-17-065259.txt : 20171212
0001209191-17-065259.hdr.sgml : 20171212
20171212181430
ACCESSION NUMBER: 0001209191-17-065259
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171208
FILED AS OF DATE: 20171212
DATE AS OF CHANGE: 20171212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRINT PAUL C
CENTRAL INDEX KEY: 0001236548
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37544
FILM NUMBER: 171252678
MAIL ADDRESS:
STREET 1: 3030 CALLAN RD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AmpliPhi Biosciences Corp
CENTRAL INDEX KEY: 0000921114
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 911549568
STATE OF INCORPORATION: WA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3579 VALLEY CENTRE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 804-827-2524
MAIL ADDRESS:
STREET 1: 3579 VALLEY CENTRE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: TARGETED GENETICS CORP /WA/
DATE OF NAME CHANGE: 19940331
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-12-08
0
0000921114
AmpliPhi Biosciences Corp
APHB
0001236548
GRINT PAUL C
C/O AMPLIPHI BIOSCIENCES CORPORATION
3579 VALLEY CENTRE DRIVE, SUITE 100
SAN DIEGO
CA
92130
1
1
0
0
Chief Executive Officer
Common Stock
2017-12-08
4
A
0
599
0.62
A
599
D
These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
/s/ Paul C. Grint
2017-12-12